The Cell and Protein Sciences division at Aragen Life Sciences offers comprehensive solutions for recombinant protein production, protein analytics, stable cell line generation, antibody discovery, and virus production. Experienced scientific teams support cell and protein sciences workflows across discovery programmes. Whether you need robust recombinant protein production, advanced protein analytics, or quality stable cell lines, our comprehensive, customizable solutions are designed to accelerate your research and development goals for small and large molecule drug discovery campaigns.
Why Us?
State-of-the-art 15,000 sq. ft. area with microbial and mammalian/insect cell culture facilities located in separate adjacent buildings in the same campus- minimizes contamination to ensure very low endotoxin levels in critical deliverables.
Our recombinant protein capabilities span multiple expression systems, including bacterial, insect/baculovirus, yeast and mammalian systems.
Leading biopharma companies are already leveraging our multi-host expression system to broaden their R&D capabilities, producing a diverse array of proteins such as cytokines, enzymes, kinases, animal vaccines, E3 Ligases, antibodies- monoclonal antibodies (mAbs), bi-specific (BsAbs), tri-specifics, scFvs, Fabs, nanobodies, etc.
100+ over-expression and reporter stable cell lines delivered to support protein production and cell-based assays.
Extensive SPR experience in screening NCEs and NBEs, supporting drug and antibody discovery programs.
